266 related articles for article (PubMed ID: 15461447)
21. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.
Durand B; Kobr M; Reith W; Mach B
Mol Cell Biol; 1994 Oct; 14(10):6839-47. PubMed ID: 7935401
[TBL] [Abstract][Full Text] [Related]
22. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes.
Louis-Plence P; Moreno CS; Boss JM
J Immunol; 1997 Oct; 159(8):3899-909. PubMed ID: 9378978
[TBL] [Abstract][Full Text] [Related]
23. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.
Durand B; Sperisen P; Emery P; Barras E; Zufferey M; Mach B; Reith W
EMBO J; 1997 Mar; 16(5):1045-55. PubMed ID: 9118943
[TBL] [Abstract][Full Text] [Related]
24. Assembly of the RFX complex on the MHCII promoter: role of RFXAP and RFXB in relieving autoinhibition of RFX5.
Garvie CW; Boss JM
Biochim Biophys Acta; 2008 Dec; 1779(12):797-804. PubMed ID: 18723135
[TBL] [Abstract][Full Text] [Related]
25. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.
Gobin SJ; Peijnenburg A; van Eggermond M; van Zutphen M; van den Berg R; van den Elsen PJ
Immunity; 1998 Oct; 9(4):531-41. PubMed ID: 9806639
[TBL] [Abstract][Full Text] [Related]
26. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
Krawczyk M; Masternak K; Zufferey M; Barras E; Reith W
Mol Cell Biol; 2005 Oct; 25(19):8607-18. PubMed ID: 16166641
[TBL] [Abstract][Full Text] [Related]
27. Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.
Krawczyk M; Peyraud N; Rybtsova N; Masternak K; Bucher P; Barras E; Reith W
J Immunol; 2004 Nov; 173(10):6200-10. PubMed ID: 15528357
[TBL] [Abstract][Full Text] [Related]
28. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
Kong X; Fang M; Li P; Fang F; Xu Y
J Mol Cell Cardiol; 2009 Mar; 46(3):292-9. PubMed ID: 19041327
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor.
Brickey WJ; Wright KL; Zhu XS; Ting JP
J Immunol; 1999 Dec; 163(12):6622-30. PubMed ID: 10586057
[TBL] [Abstract][Full Text] [Related]
30. The bare lymphocyte syndrome and the regulation of MHC expression.
Reith W; Mach B
Annu Rev Immunol; 2001; 19():331-73. PubMed ID: 11244040
[TBL] [Abstract][Full Text] [Related]
31. CREB regulates MHC class II expression in a CIITA-dependent manner.
Moreno CS; Beresford GW; Louis-Plence P; Morris AC; Boss JM
Immunity; 1999 Feb; 10(2):143-51. PubMed ID: 10072067
[TBL] [Abstract][Full Text] [Related]
32. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y.
Reith W; Siegrist CA; Durand B; Barras E; Mach B
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):554-8. PubMed ID: 8290561
[TBL] [Abstract][Full Text] [Related]
33. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation.
Seguín-Estévez Q; De Palma R; Krawczyk M; Leimgruber E; Villard J; Picard C; Tagliamacco A; Abbate G; Gorski J; Nocera A; Reith W
J Immunol; 2009 Aug; 183(4):2545-53. PubMed ID: 19620312
[TBL] [Abstract][Full Text] [Related]
34. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome.
Moreno CS; Emery P; West JE; Durand B; Reith W; Mach B; Boss JM
J Immunol; 1995 Nov; 155(9):4313-21. PubMed ID: 7594590
[TBL] [Abstract][Full Text] [Related]
35. The RFX family interacts at the collagen (COL1A2) start site and represses transcription.
Sengupta PK; Fargo J; Smith BD
J Biol Chem; 2002 Jul; 277(28):24926-37. PubMed ID: 11986307
[TBL] [Abstract][Full Text] [Related]
36. Protease treatment of nuclear extracts distinguishes between class II MHC X1 box DNA-binding proteins in wild-type and class II-deficient B cells.
Hasegawa SL; Riley JL; Sloan JH; Boss JM
J Immunol; 1993 Mar; 150(5):1781-93. PubMed ID: 8436816
[TBL] [Abstract][Full Text] [Related]
37. Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma).
Xu Y; Wang L; Butticè G; Sengupta PK; Smith BD
J Biol Chem; 2004 Oct; 279(40):41319-32. PubMed ID: 15247294
[TBL] [Abstract][Full Text] [Related]
38. Multiple interactions between BRG1 and MHC class II promoter binding proteins.
Mudhasani R; Fontes JD
Mol Immunol; 2005 Apr; 42(6):673-82. PubMed ID: 15781111
[TBL] [Abstract][Full Text] [Related]
39. CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: the invariant chain promoter as a model.
Linhoff MW; Wright KL; Ting JP
Mol Cell Biol; 1997 Aug; 17(8):4589-96. PubMed ID: 9234716
[TBL] [Abstract][Full Text] [Related]
40. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
Nagarajan UM; Peijnenburg A; Gobin SJ; Boss JM; van den elsen PJ
J Immunol; 2000 Apr; 164(7):3666-74. PubMed ID: 10725724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
